Anna Sampietro

Bachelor’s in Pharmacy (UB), MSc in Business Administration (EAE Business School and IL3-UB), PhD in Drug Discovery (UB), and MSc in Innovation and Entrepreneurship for Engineering and Health Biosciences (UB).

Her research interests and expertise span neuroscience and targeted protein degradation, with a focus on neurodegeneration, protein aggregation, and cancer.

She completed a predoctoral research stay at UC Davis, working on neuropathic pain, and later worked as a Postdoctoral Researcher at the Galdeano Lab (UB).

In June 2026, she joined Invivo Partners as an Investment Analyst Intern.